News Article

Reset Health and Pharmacy2U partner on weight loss

18 February 2026

The UK’s largest dedicated online pharmacy Pharmacy2U and UK-based digital health company Reset Health have announced a strategic partnership, marking a significant shift in the UK obesity market by combining digital pharmacy scale with specialised clinical oversight.

The collaboration, set to launch Q1 2026, pairs the UK’s largest online pharmacy with Reset Health’s experience in managing chronic diseases through a digital health platform.

The importance of this deal lies in its attempt to solve the “rebound effect” often seen in weight loss treatments, where patients regain weight after discontinuing medication. By integrating Pharmacy2U’s nationwide GLP-1 distribution and one-click repeat prescriptions with Reset Health’s “wraparound” care, the partners aim to deliver sustained clinical results rather than just transactional medication sales.

The service model includes monthly teleconsultations, evidence-based coaching, and nutrition support provided by a multidisciplinary team of dietitians and psychologists. This approach aligns with NICE guidelines, which emphasize that GLP-1 agonists like semaglutide should be part of comprehensive weight-management programs that include behavioural and physical activity components.

From an operational standpoint, this partnership streamlines the patient journey by offering a single digital gateway for both expert clinical support and medication delivery. The collaboration is also expected to generate continuous data throughout the patient journey, providing valuable insights into treatment efficacy and patient adherence.

For the broader market, this move signals a transition toward “next-generation” obesity care that prioritises long-term outcomes over short-term weight loss. Reset Health’s previous success, including securing NHS contracts for Tier 4 specialist weight management services, suggests a robust clinical foundation for this private-sector expansion.

As Reset Health has previously explored capital raises and potential listings at valuations up to £60 million, this high-profile partnership with a market leader like Pharmacy2U strengthens its position as a key player in the booming weight-loss sector. Ultimately, the deal provides a blueprint for how digital pharmacies can evolve into integrated healthcare providers by embedding specialist clinical services into the prescription fulfilment process.